title: Clinical features and anti-neural reactivity in neuropathy associated with IgG monoclonal gammopathy of undetermined significance.
abstract: Neuropathy has been frequently reported in patients with IgG monoclonal gammopathy of undetermined significance (MGUS) but it is still unclear whether this association has clinical or pathogenetic relevance. In order to clarify the possible role of IgG MGUS in the neuropathy we correlated the clinical and electrophysiological features of the neuropathy with the duration and anti-neural activity of the M-protein in 17 patients with neuropathy and IgG MGUS. Ten patients (59%) had a chronic demyelinating neuropathy clinically indistinguishable from chronic inflammatory demyelinating polyneuropathy (CIDP) while 7 (41%) had a predominantly sensory axonal or mixed neuropathy. In 80% of patients in the CIDP-like and 28% in the sensory group the IgG M-protein became manifest several months to years after onset of the neuropathy. Antibodies to one or more neural antigens (including tubulin, a 35KD P0-like nerve myelin glycoprotein, GD1a, GM1 and chondrotin sulfate C) were found in 40% of patients with CIDP-like and 43% with sensory neuropathy but also in 37% patients with IgG MGUS without neuropathy. Neuropathy associated with IgG MGUS is probably less heterogeneous than previously considered suggesting that this association may not be merely casual. The evidence for primary pathogenetic role of IgG M-proteins in the neuropathy remains however elusive.
authors.affiliation: Giorgio Spagnol Service of Clinical Neuroimmunology, Institute of Clinical Neurology, IRCCS Ospedale Maggiore Policlinico, Milan University, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Di Troia
authors.forename: M
authors.initials: M
authors.lastname: Carpo
authors.forename: N
authors.initials: N
authors.lastname: Meucci
authors.forename: C
authors.initials: C
authors.lastname: Pellegrino
authors.forename: S
authors.initials: S
authors.lastname: Allaria
authors.forename: F
authors.initials: F
authors.lastname: Gemignani
authors.forename: A
authors.initials: A
authors.lastname: Marbini
authors.forename: R
authors.initials: R
authors.lastname: Mantegazza
authors.forename: R
authors.initials: R
authors.lastname: Sciolla
authors.forename: E
authors.initials: E
authors.lastname: Manfredini
authors.forename: G
authors.initials: G
authors.lastname: Scarlato
authors.forename: E
authors.initials: E
authors.lastname: Nobile-Orazio
mesh_terms: D000328:Adult; D000368:Aged; D003711:Demyelinating Diseases / Q000097:blood* / Q000150:complications / Q000628:therapy; D005260:Female; D015417:Hereditary Sensory and Motor Neuropathy / Q000097:blood* / Q000150:complications / Q000628:therapy; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood*; D007075:Immunoglobulin M / Q000097:blood*; D007167:Immunotherapy; D008297:Male; D008875:Middle Aged; D010265:Paraproteinemias / Q000097:blood* / Q000150:complications / Q000628:therapy; D013497:Sural Nerve
chemical_list: D007074:Immunoglobulin G; D007075:Immunoglobulin M